Silver Grove Financial Group’s Chemed CHE Stock Holding History

Silver Grove Financial Group’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$466	Hold	1	–	–	﹤0.01%	2094
2026 Q1	$378	Buy	+1	New	+$428	﹤0.01%	488

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Silver Grove Financial Group's CHE Position: Q2 2026 in Review

Silver Grove Financial Group held its Chemed (CHE) position steady in Q2 2026 at 1 share worth $466. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

Silver Grove Financial Group first reported a position in CHE in Q1 2026 and has held it in 2 quarters since. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

Silver Grove Financial Group held 1 share of Chemed worth $466 as of Q2 2026.
Silver Grove Financial Group left its Chemed share count unchanged in Q2 2026.
Chemed made up ﹤0.01% of Silver Grove Financial Group's portfolio in Q2 2026, its #2094 holding.
Silver Grove Financial Group first reported a position in Chemed in Q1 2026 and has held it in 2 quarters since.
530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.